DXCM
$205.68
Dexcom
$7.60
3.84%
DXCM
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.70
Revenue:  $395.23 Mil
Wednesday
Feb 5
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Wednesday, November 06, 2019
Latest EPS
Wednesday, November 06, 2019

What do you expect when DXCM reports earnings?
Beat
Meet
Miss

Where is DXCM's stock price going from here?
Up
Flat
Down
Stock chart of DXCM
Analysts
Summary of analysts' recommendations for DXCM
Score
Grade
Pivots
Resistance
$220.86
$213.39
$209.54

$202.07

Support
$198.21
$190.74
$186.89
Tweet
Growth
Description
Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.
Peers
StrykerBecton, DickinsonBaxter InternationalBoston ScientificAbbott LaboratoriesTeleflex3MWatersAbiomedIntegra LifeSciences Holdings